[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@OzmosiHealth](/creator/twitter/OzmosiHealth)
"$IRON -XXXX% today as Disc Medicine Announces Receipt of FDA Commissioner's National Priority Voucher (CNPV) for Bitopertin in Erythropoietic Protoporphyria (EPP) More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982881805381855) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2806 followers, XXX engagements


"$OVID Ovid presented Phase X Healthy Volunteers results on 2025-10-03 for OV-329 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1975291048512385462) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-06T20:04Z 2806 followers, XXX engagements


"$MIST +1.25% today as Milestone Pharmaceuticals to Present Data on Etripamil at the American Heart Association Scientific Sessions 2025 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1976281352233271732) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-09T13:39Z 2806 followers, XXX engagements


"$CRVS -XXXX% today as Corvus Pharmaceuticals Announces Presentation of Interim Data from the Phase 1b/2 Clinical Trial of Ciforadenant for Patients with Metastatic Renal Cell Cancer at the European Society for Medical Oncology (ESMO) Congress 2025 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979254178993066188) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T18:32Z 2806 followers, XXX engagements


"$CADL -XXXX% today as Candel Therapeutics Announces Positive Interim Data After Repeated Administration of CAN-3110 in Recurrent Glioblastoma and Announces Publication in Science Translational Medicine More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978115185156960616) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T15:06Z 2800 followers, XXX engagements


"$ACET Adicet Bio dosed the first Systemic Sclerosis patient in Phase X trial of ADI-001 for Autoimmune Diseases. More Info: $XBI $IBB $XPH $PPH"  
[X Link](https://x.com/OzmosiHealth/status/1948338030974226558) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-07-24T11:02Z 2800 followers, XXX engagements


"$GALT Galectin Therapeutics Reports Financial Results for the Quarter Ended June XX 2025 and Provides Business Update"  
[X Link](https://x.com/OzmosiHealth/status/1956026282765898199) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-08-14T16:13Z 2799 followers, XXX engagements


"$LEGN Legend Biotech Appoints Carlos Santos as Chief Financial Officer"  
[X Link](https://x.com/OzmosiHealth/status/1957544501288812697) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-08-18T20:45Z 2802 followers, XXX engagements


"$KYMR +2.76% today as Kymera Therapeutics Announces Late-Breaking Oral Presentations on KT-621 a First-In-Class Oral STAT6 Degrader at the European Academy of Dermatology & Venereology and European Respiratory Society Congresses More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1968315944582701436) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-09-17T14:07Z 2800 followers, XXX engagements


"Daily $XBI Recap $BHVN +8% $ROIV +7% $XNCR +7% $VCEL -X% $CGEM -X% $SRPT -5%"  
[X Link](https://x.com/OzmosiHealth/status/1968504279926178135) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-09-18T02:36Z 2800 followers, XXX engagements


"$CYBN Cybin announced they will present Phase X Generalized anxiety disorder results in 1Q26 for CYB-004 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1970944302999060695) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-09-24T20:11Z 2800 followers, XXX engagements


"$PHAR +8.16% today as Pharming Group announces U.S. FDA acceptance and Priority Review of supplemental New Drug Application for leniolisib in children with APDS aged X to XX years More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1973383126484213950) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-01T13:42Z 2802 followers, XXX engagements


"$CSLLY as CSL Behring Signs Letter of Intent with pan-Canadian Pharmaceutical Alliance (pCPA) for Public Reimbursement of HEMGENIX (etranacogene dezaparvovec) the First Gene Therapy for Hemophilia B More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1975196189227196468) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-06T13:47Z 2800 followers, XXX engagements


"$CADL Candel Therapeutics announced they will present Phase X Prostate Cancer results on 2025-11-07 for Aglatimagene besadenovec More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1975291011816431880) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-06T20:04Z 2800 followers, XXX engagements


"$CYTK FDA extended PDUFA action date for aficamten's NDA from Sep XX 2025 to Dec XX 2025 due to REMS review. More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1975291055072227493) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-06T20:04Z 2799 followers, XXX engagements


"$ABVX Abivax presented Phase X Colitis Ulcerative results on 2025-10-06 for Obefazimod More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1975742090400182319) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-08T01:56Z 2800 followers, XXX engagements


"$GALT Galectin announced they will present Phase X Non-alcoholic Steatohepatitis results on 2025-11-10 for Belapectin More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1976016406199058687) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-08T20:06Z 2800 followers, XXX engagements


"$ACET Adicet Bio presented Phase X Autoimmune Disease Unspecified results on 2025-10-07 for Prulacabtagene leucel More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1976016429926248703) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-08T20:06Z 2800 followers, XXX engagements


"$JNJ Johnson & Johnson presented Phase X Colitis Ulcerative results on 2025-10-07 for Guselkumab More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1976016440537837718) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-08T20:06Z 2802 followers, XXX engagements


"$CYTK PDUFA date: September XX 2025 for aficamten approval from FDA misrepresented by defendants in a securities class action lawsuit. More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1976016443884896757) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-08T20:06Z 2800 followers, XXX engagements


"$RNTX -XXXX% today as Rein Therapeutics Receives European Regulatory Approval to Initiate Phase X Trial of LTI-03 in Idiopathic Pulmonary Fibrosis More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1976281340887585179) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-09T13:39Z 2800 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $SRPT Sarepta will present Phase X Muscular DystrophiesMuscular Dystrophy Duchenne Data for Delandistrogene moxeparvovec (Gene TherapyDMD - Gene Therapy) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1976606737718489393) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-10T11:12Z 2802 followers, 1364 engagements


"$ONC +2.86% today as BeOne Medicines' Sonrotoclax Granted Breakthrough Therapy Designation by U.S. FDA More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1977752758724739311) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-13T15:06Z 2802 followers, XXX engagements


"$JNJ Johnson & Johnson presented Phase X Depressive Disorder Major results on 2025-10-12 for Lumateperone More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1977833538520039576) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-13T20:27Z 2802 followers, XXX engagements


"$IMAB +1.64% today as I-Mab to Present Short-Talk on Updated Givastomig Monotherapy Data at the 2025 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978115152986714261) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T15:06Z 2802 followers, XXX engagements


"$SPRO +0.18% today as Spero Therapeutics Announces Presentations on Tebipenem Hbr at IDWeek More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978115177359769777) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T15:06Z 2799 followers, XXX engagements


"$RPTX Repare Therapeutics announced they will present Phase X Oncology Solid Tumor Unspecified results on 2025-10-25 for RP-1664 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216532002968054) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:49Z 2800 followers, XXX engagements


"$CYTK PDUFA Summary: Cytokinetics misled investors about FDA approval timeline for Aficamten leading to stock price inflation and losses. More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216561786691598) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:49Z 2800 followers, XXX engagements


"$CYTK PDUFA Summary: FDA extended action date for Aficamten NDA to December XX 2025. Stock price fell on disclosure. More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216565318337012) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:49Z 2798 followers, XXX engagements


"$AUPH +0.93% today as Aurinia Announces Upcoming Presentations of New Data on LUPKYNIS at American College of Rheumatology Convergence and American Society of Nephrology Kidney Week 2025 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978458211301683405) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-15T13:49Z 2802 followers, XXX engagements


"Pelage Pharmaceuticals raised $120M Series B to develop PP405 a regenerative hair-loss therapy"  
[X Link](https://x.com/OzmosiHealth/status/1978515356558766185) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-15T17:36Z 2800 followers, XXX engagements


"Lillys oral GLP-1 orforglipron outperformed Novos Rybelsus in Phase III on glucose control and weight loss when paired with AstraZenecas Farxiga"  
[X Link](https://x.com/OzmosiHealth/status/1978515357959586038) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-15T17:36Z 2800 followers, XXX engagements


"Ahead of its first clinical readout Tubulis raises 308M to fuel its ADC (antibody-drug conjugate) ambitions"  
[X Link](https://x.com/OzmosiHealth/status/1978515358857204092) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-15T17:36Z 2802 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $MRNA Moderna will present Phase X Melanoma Data for mRNA-4359 (Relaxin Analogue - Nucleic Acid) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1978781067776770282) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T11:12Z 2802 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $MRNA Moderna will present Phase X Bladder CancerMuscle Cancer Data for Intismeran autogene (Vaccine - Nucleic Acid) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1978781068372377668) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T11:12Z 2802 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $PFE Pfizer will present Phase X Cachexia Data for Ponsegromab (GDF15 Inhibitor - Antibody) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1978781071811731689) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T11:12Z 2802 followers, XXX engagements


"$NVCT +1.24% today as Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978820986418958532) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T13:51Z 2802 followers, XXX engagements


"$OMER -XXXXX% today as Omeros Announces Publication Highlighting Survival Benefits in TA-TMA Patients Treated with Narsoplimab Versus a Well-Matched External Control Group More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978820994841071676) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T13:51Z 2802 followers, XXX engagements


"$APS as Aptose's Tuspetinib Exceeds Expectations When Combined with Standard of Care Treatment Across Diverse Populations of Newly Diagnosed AML More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978821003905032309) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T13:51Z 2802 followers, XXX engagements


"$LIXT -XXXX% today as LIXTE Biotechnology Holdings Highlights Q4 2025 Priorities Including Ongoing Advancement of Lead Candidate LB-100 Strategic Oncology Business Development and Acquisition Plans More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978821012515905636) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T13:51Z 2802 followers, XXX engagements


"$NXTC +3.93% today as NextCure and Simcere Zaiming Announce Expansion of Ongoing Phase X Trial of SIM0505 (CDH6 ADC) into the United States More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978821016164962550) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T13:51Z 2802 followers, XXX engagements


"$PRAX +203.36% today as Praxis Precision Medicines Announces Positive Topline Results from Two Pivotal Phase X Studies of Ulixacaltamide HCl in the Essential3 Program for Essential Tremor More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978821020107596075) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T13:51Z 2802 followers, XXX engagements


"$ENTX +1.88% today as Entera Bio to Present New Clinical Data from Phase X Trial of EB613 at the 2025 North American Menopause Society (NAMS) Annual Meeting More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978821024339644702) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T13:51Z 2802 followers, XXX engagements


"Sanofi will explore using EVOQs platform to craft autoimmune therapies aimed at restoring immune balance"  
[X Link](https://x.com/OzmosiHealth/status/1978828028076601523) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T14:19Z 2802 followers, XXX engagements


"Novartis advances Fabhalta (iptacopan) toward full FDA approval in IgA nephropathy (IgAN) preparing a submission next year"  
[X Link](https://x.com/OzmosiHealth/status/1978828030463091145) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T14:19Z 2802 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $AZN AstraZeneca will present Phase X Breast Cancer Data for Trastuzumab deruxtecan (ERBB2 InhibitorTOP2 Inhibitor - Antibody Drug Conjugate) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1979143454308602004) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T11:12Z 2802 followers, XXX engagements


"$ABSI AbSci announced they will present P1 Alopecia Areata results in 2H26 for ABS-201 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982913505927386) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2806 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $INCY Incyte will present Phase X Oncology Solid Tumor Unspecified Data for INCB-161734 (KRAS G12D Inhibitor - Small Molecule) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1979505841402519645) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-18T11:12Z 2806 followers, XXX engagements


"$IMMP Immutep's Efti combined with KEYTRUDA and Chemotherapy shows strong response rates in treating First-Line Non-Small Cell Lung Cancer. More Info: $XBI $IBB $XPH $PPH"  
[X Link](https://x.com/OzmosiHealth/status/1922993538377363966) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-05-15T12:32Z 2801 followers, XXX engagements


"$DYN Dyne Therapeutics gets FDA Breakthrough Therapy Designation for DYNE-251 in Duchenne Muscular Dystrophy. More Info: $XBI $IBB $XPH $PPH"  
[X Link](https://x.com/OzmosiHealth/status/1952331857548501040) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-08-04T11:32Z 2802 followers, XXX engagements


"$PLX Protalix BioTherapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference"  
[X Link](https://x.com/OzmosiHealth/status/1962917963918430501) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-09-02T16:38Z 2802 followers, XXX engagements


"$IMAB -XXXX% today as I-Mab Announces Acceleration of Givastomig Investment and Leadership Appointments More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1965048374635229371) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-09-08T13:43Z 2802 followers, XXX engagements


"$RARE Ultragenyx presented Phase X Glycogen Storage Disease Type Ia results on 2025-09-08 for Pariglasgene brecaparvovec More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1965510301836550471) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-09-09T20:19Z 2802 followers, XXX engagements


"$INCY Incyte announced they will present Phase X Hidradenitis Suppurativa results on 2025-09-17 for Povorcitinib More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1966235516308779295) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-09-11T20:20Z 2802 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $INCY Incyte will present Phase X Hidradenitis Suppurativa Data for Povorcitinib (JAK1 Inhibitor - Small Molecule) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1967909432156885172) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-09-16T11:12Z 2802 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $INCY Incyte will present Phase X Prurigo Data for Ruxolitinib (JAK1 InhibitorJAK2 InhibitorSTAT Inhibitor - Small Molecule) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1967909432853200947) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-09-16T11:12Z 2802 followers, XXX engagements


"$INCY +1.20% today as Incyte Announces New 24-Week Phase X Data from the STOP-HS Clinical Trial Program of Povorcitinib in Hidradenitis Suppurativa at EADV 2025 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1968315936479302065) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-09-17T14:07Z 2802 followers, XXX engagements


"$CYTK Cytokinetics presented Phase X Cardiomyopathy Hypertrophic results on 2025-09-29 for Aficamten More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1973176131751735422) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-01T00:00Z 2802 followers, XXX engagements


"$BOLT +8.85% today as Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1973487513575551439) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-01T20:37Z 2802 followers, XXX engagements


"$CYTK Cytokinetics faced a setback when the U.S. FDA delayed approval for aficamten beyond the expected September XX 2025 PDUFA date. More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1975291051993702632) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-06T20:04Z 2802 followers, XXX engagements


"$NBIX Neurocrine presented Phase X Huntington Disease results on 2025-10-06 for Valbenazine More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1975742106305012079) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-08T01:56Z 2801 followers, XXX engagements


"$NGNE +11.06% today as Neurogene Announces Positive Regulatory Update for NGN-401 Gene Therapy in Rett Syndrome with Plans to Initiate Dosing in Embolden Registrational Trial in Q4 2025 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1976281356079374497) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-09T13:39Z 2802 followers, XXX engagements


"Regeneron is preparing an FDA submission for DB-OTO its gene therapy for profound genetic hearing loss following updated trial data"  
[X Link](https://x.com/OzmosiHealth/status/1977727709166870914) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-13T13:26Z 2803 followers, XXX engagements


"$ZLAB +3.61% today as Zai Lab Announces Oral Presentation of Updated Data from Global Phase X Trial of Zocilurtatug Pelitecan (ZL-1310) a Potential First-in-Class DLL3-Targeted ADC at 2025 AACR-NCI-EORTC Conference More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1977830362504974601) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-13T20:14Z 2802 followers, XXX engagements


"$GMAB -XXXX% today as Genmab Announces Net Sales of DARZALEX (daratumumab) for Third Quarter of 2025 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978115140588314652) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T15:06Z 2801 followers, XXX engagements


"$BMY Bristol-Myers Squibb announced they will present Phase X Non-Small-Cell Lung Cancer results on 2025-10-17 for Izalontamab brengitecan More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216480001994888) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:48Z 2802 followers, XXX engagements


"$BMY Bristol-Myers Squibb announced they will present Phase X Ovarian Cancer results on 2025-10-19 for Izalontamab brengitecan More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216484070379767) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:48Z 2802 followers, XXX engagements


"$BMY Bristol-Myers Squibb announced they will present Phase X Colorectal Cancer results on 2025-10-20 for Nivolumab More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216488180883473) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:48Z 2802 followers, XXX engagements


"$BMY Bristol-Myers Squibb announced they will present Phase X Nasopharyngeal Cancer results on 2025-10-19 for Izalontamab brengitecan More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216491569852477) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:48Z 2802 followers, XXX engagements


"$GILD Gilead Sciences announced they will present Phase X Esophageal CancerGastrointestinal Cancer results on 2025-10-18 for Domvanalimab More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216507248193570) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:49Z 2801 followers, XXX engagements


"$GILD Gilead Sciences announced they will present Phase X Esophageal CancerGastrointestinal Cancer results on 2025-10-18 for Zimberelimab More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216511501160861) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:49Z 2801 followers, XXX engagements


"$GILD Gilead Sciences announced they will present Phase X Triple Negative Breast Cancer results on 2025-10-19 for Sacituzumab govitecan More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216515494129718) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:49Z 2801 followers, XXX engagements


"$ZLAB Zai Lab announced they will present Phase X Small Cell Lung Cancer results on 2025-10-24 for Zocilurtatug pelitecan More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216544233455729) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:49Z 2802 followers, XXX engagements


"$ENVB +15.46% today as Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin Recently Acquired by AbbVie in $XXX Billion Deal More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978458191911321919) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-15T13:49Z 2802 followers, XXX engagements


"$VTRS +0.70% today as Viatris Completes Acquisition of Aculys Pharma Including Exclusive Rights to Pitolisant in Japan and to Spydia in Japan and Certain Other Markets in the Asia-Pacific Region More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978597902680277123) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-15T23:04Z 2802 followers, XXX engagements


"$SONN -XXXX% today as Evaluation of SON-1010 Using a Patient-Derived Tumoroid Platform to Support an Ongoing Phase X Study in Patients with Sarcoma More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978597906501284108) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-15T23:04Z 2801 followers, XXX engagements


"$IMAB I-Mab Biopharma announced they will present P1 Gastrointestinal Cancer results on 2025-10-23 for Givastomig More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978597954693759212) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-15T23:04Z 2801 followers, XXX engagements


"$SPRO Spero announced they will present P3 Urinary Tract InfectionsNephritisPyelonephritis results on 2025-10-20 for Tebipenem pivoxil More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978597973127782667) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-15T23:04Z 2802 followers, XXX engagements


"$CADL Candel Therapeutics presented P1 Glioblastoma results on 2025-10-14 for CAN-3110 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978597983886184772) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-15T23:04Z 2802 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $INCY Incyte will present Phase X Oncology Solid Tumor Unspecified Data for INCA-33890 (PD-1 InhibitorTGFBR2 Inhibitor - Bispecific Antibody) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1978781064199041326) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T11:12Z 2802 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $KURA Kura Oncology will present Preclinical Oncology Solid Tumor Unspecified Data for Darlifarnib (FT Inhibitor - Small Molecule) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1978781071153242458) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T11:12Z 2802 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $HCM HUTCHMED will present Phase X Soft Tissue Cancer Data for Surufatinib (VEGFR1 AntagonistVEGFR2 InhibitorVEGFR3 AntagonistFGFR Antagonist - Small Molecule) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1978781072373788896) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T11:12Z 2803 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $HCM HUTCHMED will present Phase X Non-Small-Cell Lung Cancer Data for Savolitinib (C-Met InhibitorTK Inhibitor - Small Molecule) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1978781073002905645) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T11:12Z 2803 followers, XXX engagements


"$MIRA +63.64% today as MIRA Pharmaceuticals Announces Oral Mira-55 Outperformed Injected Morphine in Normalizing Pain and Reducing Inflammation Supporting Its Planned IND for Chronic Inflammatory Pain More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978820982543405434) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T13:51Z 2802 followers, XXX engagements


"$ALGS +4.39% today as Aligos Therapeutics Receives USAN Council Approval for pevifoscorvir sodium as Nonproprietary Name for ALG-000184 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978820990701355463) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T13:51Z 2802 followers, XXX engagements


"$ACET +3.13% today as Adicet Bio Announces First Patient Dosed in Phase X Clinical Trial of ADI-001 in Treatment-Refractory Rheumatoid Arthritis (RA) More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978820998859231488) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T13:51Z 2802 followers, XXX engagements


"$KZR -XXXX% today as Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis and Plans to Explore Strategic Alternatives More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982862066946545) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2802 followers, XXX engagements


"$RHHBY +0.65% today as Genentech Expands Xofluza Access and Affordability for Upcoming Flu Season With Direct-to-Patient Launch More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982866395570330) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2802 followers, XXX engagements


"$CLLS +9.20% today as Cellectis' R&D Day Highlights Lasme-cel's Potential to Address Significant Unmet Need for Patients with r/r B-ALL More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982869843190122) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2802 followers, XXX engagements


"$TSHA -XXXX% today as Taysha Gene Therapies Regains Full Rights to Lead TSHA-102 Program in Clinical Evaluation for the Treatment of Rett Syndrome More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982873320292815) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2802 followers, XXX engagements


"$ATAI -XXXX% today as atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003 Underscoring its Potential in Treatment-Resistant Depression More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982877569114112) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2802 followers, XXX engagements


"$RVMD +0.22% today as Revolution Medicines Awarded Voucher for Daraxonrasib (RMC-6236) Under FDA Commissioner's National Priority Voucher Pilot Program More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982885718663245) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2802 followers, XXX engagements


"$MNPR Monopar Therapeutics announced they will present P2 Hepatolenticular Degeneration results on 2025-11-09 for Tiomolibdic acid More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982917486342508) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2802 followers, XXX engagements


"$SMMT Summit announced they will present P3 Non-Small-Cell Lung Cancer results on 2025-10-19 for Ivonescimab More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982921441566901) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2802 followers, XXX engagements


"$ARGX argenx announced they will present P3 Myasthenia Gravis results on 2025-10-29 for Efgartigimod More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982924838986225) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2802 followers, XXX engagements


"$ARTL Artelo Biosciences presented P1 Healthy Volunteers results on 2025-10-16 for ART26.12 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982928718659885) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2802 followers, XXX engagements


"$ARTL Artelo Biosciences presented P2 Anorexia results on 2025-10-16 for ART27.13 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982932543926314) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2802 followers, XXX engagements


"$GILD Gilead Sciences presented P2 HIV Infections results on 2025-10-15 for Lenacapavir More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982936855584910) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2802 followers, XXX engagements


"$GILD Gilead Sciences presented P2 HIV Infections results on 2025-10-15 for Teropavimab More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982940295000348) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2802 followers, XXX engagements


"$GILD Gilead Sciences presented P2 HIV Infections results on 2025-10-15 for Zinlirvimab More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982943717519679) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2802 followers, XXX engagements


"$MRK Merck presented P3 HIV Infections results on 2025-10-15 for Doravirine More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982947051933908) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2802 followers, XXX engagements


"$MRK Merck presented P3 HIV Infections results on 2025-10-15 for Islatravir More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978982950545887710) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T00:34Z 2802 followers, XXX engagements


"TrumpRx brings Merck KGaA onboard its voucher program as one of nine recipients accelerating review of IVF therapy Pergoveris"  
[X Link](https://x.com/OzmosiHealth/status/1979177248394490052) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:26Z 2802 followers, XXX engagements


"$BMRN Biomarin presented Phase X Achondroplasia results on 2025-09-08 for Vosoritide More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1965510263928492045) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-09-09T20:18Z 2806 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $MRK Merck will present Phase X HIV Infections Data for Islatravir (NRT Inhibitor - Small Molecule) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1978418677235232938) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-15T11:12Z 2806 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $ALPMY Astellas Pharma will present Phase X Bladder CancerMuscle Cancer Data for Enfortumab vedotin (NECTIN4 Inhibitor - Antibody Drug Conjugate) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1979143454992273713) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T11:12Z 2806 followers, XXX engagements


"Kezar considers strategic options after FDA clash implements cost cuts and layoffs aiming to preserve value amid regulatory pressure"  
[X Link](https://x.com/OzmosiHealth/status/1979177249237528692) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:26Z 2804 followers, XX engagements


"AstraZeneca expands its AI discovery pact with Immunaideals worth up to $85M to extend AI-based work beyond oncology"  
[X Link](https://x.com/OzmosiHealth/status/1979177250705592395) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:26Z 2804 followers, XX engagements


"$SNSE -XXXXX% today as Sensei Biotherapeutics Reports New Clinical Results Highlighting Durable Progression Free Survival Data for Solnerstotug in PD-(L)1 Resistant Tumors at the ESMO Congress 2025 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183711443628141) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2805 followers, XXX engagements


"$AZN +0.47% today as IMFINZI (durvalumab) regimen reduced the risk of disease recurrence or death by XX% in high-risk non-muscle-invasive bladder cancer in the POTOMAC Phase III trial More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183718938837337) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2804 followers, XXX engagements


"$TNXP -XXXX% today as Tonix Pharmaceuticals Presented Data on TNX-801 Mpox Vaccine at World Vaccine CongressEurope 2025 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183731496583412) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2805 followers, XXX engagements


"$REGN +0.97% today as Libtayo (cemiplimab) Recommended for EU Approval by the CHMP for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma (CSCC) with a High Risk of Recurrence After Surgery and Radiation More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183734944366997) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2806 followers, XXX engagements


"$LLY -XXXX% today as Lilly's Verzenio (abemaciclib) prolonged survival in HR+ HER2- high-risk early breast cancer with two years of treatment More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183739218305424) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2805 followers, XXX engagements


"$VRTX +0.99% today as Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183742896795862) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2805 followers, XX engagements


"$OSTX -XXXX% today as OS Therapies Granted Final Type C Meeting by U.S. FDA and pre-MAA Meeting by U.K. MHRA for OST-HER2 in the Prevention or Delay of Recurrent Fully Resected Pulmonary Metastatic Osteosarcoma More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183746927493138) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2805 followers, XXX engagements


"$ABBV +1.15% today as AbbVie Completes Acquisition of Gilgamesh Pharmaceuticals' Bretisilocin More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183758356971710) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2805 followers, XXX engagements


"$PLX -XXXXX% today as Chiesi Global Rare Diseases and Protalix Biotherapeutics Acknowledge CHMP Negative Opinion on Every Four Week Dosing Regimen of Elfabrio (pegunigalsidase alfa) in the EU More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183761796333833) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2806 followers, XXX engagements


"$EVAX -XXXXX% today as Evaxion reports XX% Objective Response Rate in phase X trial with AI-designed personalized cancer vaccine EVX-01 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183765873144032) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2806 followers, XXX engagements


"$PHGE +4.94% today as BiomX Provides a Program Update and Announces New FDA Feedback Potentially Expanding BX004 Development Pathways More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183769987760560) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2805 followers, XXX engagements


"$SNY +1.13% today as Press Release: Sanofi provides update on regulatory review in the EU for Rezurock to treat chronic graft-vs-host disease More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183773276156251) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2804 followers, XXX engagements


"$INSM +1.54% today as CHMP Recommends EU Approval of BRINSUPRI (brensocatib) for the Treatment of Non-Cystic Fibrosis Bronchiectasis More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183780930658678) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2806 followers, XXX engagements


"$NBIX +1.56% today as Neurocrine Biosciences Presents New KINECT X Post-Hoc Analysis Demonstrating Rapid and Sustained Therapeutic Efficacy of INGREZZA (valbenazine) XX mg Capsules More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183784164508082) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2805 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $PFE Pfizer will present Phase X Breast Cancer Data for Vepdegestrant (ER Degrader - Small Molecule) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1979868231952400652) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-19T11:12Z 2806 followers, XXX engagements


"$CGEN Compugen announced they will present Phase X Oncology Solid Tumor Unspecified results on 2025-11-07 for GS-0321 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1975742070296842573) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-08T01:56Z 2806 followers, XXX engagements


"Ypsomed will invest $248M to build its first U.S. manufacturing site expanding its injection systems footprint there"  
[X Link](https://x.com/OzmosiHealth/status/1976646952130404844) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-10T13:52Z 2806 followers, XXX engagements


"Daily $XBI Summary $ATYR +15% $MLYS +3% $CDTX +3% $NRIX -X% $BHVN -X% $SYRE -4%"  
[X Link](https://x.com/OzmosiHealth/status/1976663478602543173) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-10T14:57Z 2806 followers, XXX engagements


"$ANAB +5.29% today as Anaptys Announces Late-Breaking Oral Presentation of Complete Phase 2b Data for Rosnilimab in Rheumatoid Arthritis at Upcoming ACR Convergence 2025 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1977752790442168826) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-13T15:06Z 2806 followers, XXX engagements


"$CGEN +12.61% today as Compugen to Present Pooled Analysis of COM701 in Three Phase X Trials in Patients with Platinum Resistant Ovarian Cancer at ESMO 2025 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1977752804878913560) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-13T15:06Z 2806 followers, XXX engagements


"$VOR -XXXX% today as Telitacicept Demonstrates Clinically Meaningful and Statistically Significant Impact on ESSDAI Compared to Placebo in Late-Breaking China Phase X Results in Primary Sjgren's Disease at ACR 2025 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978115204887024125) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T15:06Z 2806 followers, XXX engagements


"$CGEN Compugen announced they will present Phase X Ovarian Cancer results on 2025-10-18 for COM-701 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978216499065036988) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-14T21:49Z 2806 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $MRK Merck will present Phase X HIV Infections Data for Doravirine (NNRT Inhibitor - Small Molecule) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1978418677822484896) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-15T11:12Z 2806 followers, XXX engagements


"$VOR -XXXX% today as Vor Bio Announces Publication of China Phase X Study of Telitacicept in Systemic Lupus Erythematosus in The New England Journal of Medicine More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1978821008250310898) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-16T13:51Z 2806 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $CGEN Compugen will present Phase X Ovarian Cancer Data for COM-701 (PVRIG Inhibitor - Antibody) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1979143452362445267) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T11:12Z 2806 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $PFE Pfizer will present Phase X Bladder CancerMuscle Cancer Data for Enfortumab vedotin (NECTIN4 Inhibitor - Antibody Drug Conjugate) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1979143453578838476) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T11:12Z 2806 followers, XXX engagements


"$SMMT +1.05% today as Summit Therapeutics Announces Expansion of Ivonescimab Global Phase III Development Program with HARMONi-GI3 Study in 1L Colorectal Cancer More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183707937247668) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2806 followers, XXX engagements


"$AZN +0.47% today as IMFINZI (durvalumab)-based regimen reduced the risk of death by XX% in early gastric cancer vs. chemotherapy alone in MATTERHORN Phase III trial More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183715235311835) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2806 followers, XXX engagements


"$AGIO +5.11% today as Avanzanite Bioscience's Partner Agios Announces Positive CHMP Opinion for PYRUKYND (mitapivat) for Adults with Thalassemia More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183723116482883) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2806 followers, XXX engagements


"$ELDN +2.81% today as Eledon Pharmaceuticals to Present Results from Phase X BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology Kidney Week 2025 Annual Meeting More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183726903845232) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2806 followers, XXX engagements


"$KNSA -XXXX% today as Kiniksa Pharmaceuticals Announces U.S. Orphan Drug Designation for KPL-387 for the Treatment of Pericarditis More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183750706545083) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2806 followers, XXX engagements


"$AGIO +5.11% today as Agios' PYRUKYND (mitapivat) Receives Positive CHMP Opinion for Adults with Thalassemia More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183754150039735) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2806 followers, XXX engagements


"$PFE +0.64% today as ViiV Healthcare announces 96-week data reaffirming Dovato is as effective as Biktarvy in maintaining virological suppression of HIV-1 with significantly less weight gain More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183776849596644) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2806 followers, XXX engagements


"$IRON +23.72% today as Disc Medicine to Present Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2025 American Society of Nephrology (ASN) Kidney Week More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979183788321026470) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2806 followers, XXX engagements


"$4568 as DATROWAY Plus Rilvegostomig Showed Promising Tumor Responses in Patients with Metastatic Urothelial Cancer in TROPION-PanTumor03 Phase X Trial More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1979254182574997966) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T18:32Z 2806 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $INCY Incyte will present Phase X Head and Neck Cancer Data for Retifanlimab (PD-1 Inhibitor - Antibody) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1979505842132251004) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-18T11:12Z 2806 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $BMY Bristol-Myers Squibb will present Phase X Colorectal Cancer Data for Ipilimumab (CTLA4 Inhibitor - Antibody) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1979868233957318902) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-19T11:12Z 2806 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $BMY Bristol-Myers Squibb will present Phase X Colorectal Cancer Data for Nivolumab (PD-1 Inhibitor - Antibody) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1979868234624192636) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-19T11:12Z 2806 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $LLY Eli Lilly will present Phase X Breast Cancer Data for Tersolisib (PI3K Inhibitor - Small Molecule) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1979868235278524441) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-19T11:12Z 2806 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $LLY Eli Lilly will present Phase X Breast Cancer Data for Imlunestrant (ER Degrader - Small Molecule) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1979868235937051108) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-19T11:12Z 2806 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $ARVN Arvinas will present Phase X Breast Cancer Data for Vepdegestrant (ER Degrader - Small Molecule) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1979868237203722674) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-19T11:12Z 2806 followers, XXX engagements


"🚀🚨 BIOPHARM CATALYST ALERT 📆 $BCTX BriaCell will present Phase X Breast Cancer Data for SV-BR-1-GM (Cell Therapy - Cell Therapy) tomorrow 👀"  
[X Link](https://x.com/OzmosiHealth/status/1979868238491341299) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-19T11:12Z 2806 followers, XXX engagements